Prostate Cancer - Results from #24260

The prostate cancer screening controversy: Addressing bioethical concerns at a community health promotion event for men - Abstract December 14, 2012

Multivitamins in the prevention of cancer in men: The Physicians' Health Study II randomized controlled trial - Abstract December 14, 2012

Pathophysiology and therapy of castration-resistant prostate cancer - Abstract December 14, 2012

Quality of Life and the mCRPC Patient December 13, 2012

Abiraterone in metastatic prostate cancer without previous chemotherapy - Abstract December 12, 2012

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): Secondary endpoints from a randomised phase 3 factorial trial - Abstract December 12, 2012

Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: Single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive December 12, 2012

Peter Scardino, MD, chief of surgery at Memorial Sloan-Kettering Cancer, talks about the practicality of prostate cancer screening December 12, 2012

History of prostate cancer: Diagnosis and treatment timeline - 1904 to 2012 December 12, 2012

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy - Abstract December 12, 2012

Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer - Abstract December 12, 2012

Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups - Abstract December 12, 2012

Epidemiology and risk factors of the prostate cancer - Abstract December 12, 2012

Preoperative therapy for localized prostate cancer: A comprehensive overview - Abstract December 12, 2012

Chromosome damage and cell proliferation rates in in vitro irradiated whole blood as markers of late radiation toxicity after radiation therapy to the prostate - Abstract December 12, 2012

The art and science of medicine: Advanced treatment for prostate cancer December 12, 2012

FDA expands Zytiga’s use for late-stage prostate cancer December 11, 2012

Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy - Abstract December 11, 2012

Radiotherapy in the treatment of advanced and recurrent prostate cancer - Abstract December 11, 2012

Increased risk of cancer mortality associated with cadmium exposures in older americans with low zinc intake - Abstract December 11, 2012

Page 1214 of 1438